Search results
Emcure Pharma shares zoom over 31% in debut trade | Business Insider India
Business Insider India· 15 hours agoLater, the company's stock zoomed 37.30 per cent to Rs 1,384 on BSE and 37.40 per cent to Rs 1,385...
Emcure Pharmaceuticals IPO: Issue booked 4.98 times on the second bidding day. Check latest GMP,...
Livemint· 6 days agoEmcure Pharmaceuticals IPO subscription status: Emcure Pharmaceuticals, backed by Bain Capital,...
Emcure Pharma IPO Allotment Today: How To Check Status, Know GMP - News18
News18· 3 days agoEmcure Pharma IPO Allotment Today: Unlisted shares of Emcure Pharma Ltd are trading Rs 390 higher in...
Emcure Pharma IPO allotment on July 08; Here’s step-by-step guide to check status
Financial Express· 3 days agoThe raised proceeds will be used to pay the outstanding borrowings availed by the company and other...
Cloud storage firm Nasuni valued at about $1.2 bln in majority investment led by Vista - ET Telecom
The Economic Times· 18 hours agoCloud storage firm Nasuni has been valued at about $1.2 billion through a majority investment led by...
Budget 2024 may propel a key element of the Modi govt's Panchamrit goals
The Economic Times· 14 hours agoBudget 2024: Sustainability through clean energy- From Nitin Gadkari to Hardeep Singh Puri and...
Funding into AI-focused startups more than doubles to $24 bn in Q2
Business Standard India· 1 day agoInvestments in artificial intelligence (AI) startups surged to $24 billion from April to June, more...
Emcure Pharma IPO: Namita Thapar-backed issue may debut with 30% gains amid high investor interest -...
CNBC TV18· 2 days agoThe grey market premium (GMP) of Emcure Pharmaceuticals has jumped sharply following the closure of...
Emcure Pharma IPO: GMP surges on last day; issue subscribed 24 times so far - CNBC TV18
CNBC TV18· 6 days agoThe initial share sale of Emcure Pharmaceuticals was off to a strong start on the last day of the...
Bansal Wire Lists At 39% Premium, Emcure Pharma Gains 31% At Debut
Latest India News· 16 hours agoBoth Bansal Wire and Emcure Pharmaceuticals IPO closed for public subscription on July 5.